RuhlJ, AdamoM, DickieL. (February2016). SEER Program Coding and Staging Manual 2016: Section V. National Cancer Institute, Bethesda, MD20850–9765.
RuhlJ, AdamoM, DickieL. (February2016). SEER Program Coding and Staging Manual 2016: Section V. National Cancer Institute, Bethesda, MD20850–9765.)| false
National Cancer Institute. Surveillance, Epidemiology, and End Results. Radiation/Chemotherapy Databases (1975–2016). Accessed July 6, 2020. Available at:https://seer.cancer.gov/data/treatment.html
National Cancer Institute. Surveillance, Epidemiology, and End Results. Radiation/Chemotherapy Databases (1975–2016). Accessed July 6, 2020. Available at:https://seer.cancer.gov/data/treatment.html)| false
LimYJ, SongC, KimJS. Improved survival with postoperative radiotherapy in thymic carcinoma: a propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database. Lung Cancer2017;108:161–167.
LimYJ, SongC, KimJS. Improved survival with postoperative radiotherapy in thymic carcinoma: a propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database. Lung Cancer 2017;108:161–167.2862563010.1016/j.lungcan.2017.03.020)| false
SullivanJ, WekslerB. Neuroendocrine tumors of the thymus: analysis of factors affecting survival in 254 patients. Ann Thorac Surg 2017;103:935–939.2772036710.1016/j.athoracsur.2016.07.050)| false
NooneAM, LundJL, MariottoA, Comparison of SEER treatment data with Medicare claims. Med Care 2016;54:e55–64.2463812110.1097/MLR.0000000000000073)| false
